drugset / Trial / NCT01364558

A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers

NCT01364558

Phase 1 Completed 24 enrolled University of Minnesota Neurelis, Inc. · collab
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this clinical research study is to assess the bioavailability and pharmacokinetics of two formulations of diazepam after intranasal (nasal spray) and injectable diazepam after intravenous (I.V.) administration

Timeline

Start
2011-02
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 5 mg Intranasal
Subject Diazepam Small molecule 10 mg Intranasal

Indications